[{"NetIncomeLoss_2_Q2_USD":-68511000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":11978000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":62344718.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":62399034.0,"AccruedLiabilitiesCurrent_0_Q2_USD":9975000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-25000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":11256000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":144539000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2158388.0,"AssetsCurrent_0_Q2_USD":316045000.0,"OperatingLeaseExpense_2_Q2_USD":2500000.0,"OperatingLeaseExpense_1_Q2_USD":1300000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":30098000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":22448000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":1701000.0,"CommonStockSharesIssued_0_Q2_shares":65106873.0,"Assets_0_Q2_USD":327511000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":87000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-38000.0,"ShareBasedCompensation_2_Q2_USD":17829000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":9559000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":13664252.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":29.43,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"InterestReceivableCurrent_0_Q2_USD":409000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":25.79,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2175000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":451000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":26000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2880000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":692000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":46070000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":25677000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":23.4,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":9615000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":175000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":61000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-973000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-408000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.9506,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.9473,"OperatingLeaseLiability_0_Q2_USD":9164000.0,"CommonStockValue_0_Q2_USD":7000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":51000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-68424000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-37626000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":2689000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0083,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0107,"OtherAssetsNoncurrent_0_Q2_USD":692000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":225447000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4334000.0,"Liabilities_0_Q2_USD":25042000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":6097072.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-16000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":6723000.0,"ShortTermInvestments_0_Q2_USD":87890000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1638000.0,"OperatingIncomeLoss_2_Q2_USD":-68518000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_2_Q2_USD":-41000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":3000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":9726000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":61000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-22000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-41814000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":4560000.0,"LiabilitiesCurrent_0_Q2_USD":20708000.0,"AccountsPayableCurrent_0_Q2_USD":4202000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2299000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":192431000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":159000.0,"CommonStockSharesOutstanding_0_Q2_shares":62792043.0,"CapitalizedComputerSoftwareAmortization1_2_Q2_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0476,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-68511000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-37588000.0,"ShortTermLeaseCost_2_Q2_USD":200000.0,"ShortTermLeaseCost_1_Q2_USD":100000.0,"AdditionalPaidInCapital_0_Q2_USD":496101000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":225447000.0,"OperatingLeasePayments_2_Q2_USD":2300000.0,"OperatingLeasePayments_1_Q2_USD":1100000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1215000.0,"NetIncomeLoss_1_Q2_USD":-37588000.0,"CapitalizedComputerSoftwareAmortization1_1_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":102786000.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"OperatingIncomeLoss_1_Q2_USD":-37655000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":87890000.0,"InvestmentIncomeInterest_2_Q2_USD":980000.0,"InvestmentIncomeInterest_1_Q2_USD":475000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":33.73,"PreferredStockValue_0_Q2_USD":null,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":327511000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":17829000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":9726000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":34225.0,"OperatingExpenses_2_Q2_USD":68518000.0,"OperatingExpenses_1_Q2_USD":37655000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3089000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.6,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.1,"ProfitLoss_2_Q2_USD":-68511000.0,"StockholdersEquity_0_Q2_USD":302469000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":363000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":87887000.0,"ManagementFeeExpense_2_Q2_USD":300000.0,"ManagementFeeExpense_1_Q2_USD":100000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-193614000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4830000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1156000.0,"Ticker":"ALVR","CIK":"1754068","name":"ALLOVIR, INC.","OfficialName":"AlloVir Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"339041308.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]